Dr. Patrick Forde, director of the Thoracic Cancer Clinical Research Program and associate professor of oncology at Johns Hopkins Medicine, gives an update on how COVID-19 is affecting treatment at his institution:
- Surgery: Paused.
- Clinical trials: Paused with a few exceptions.
- Consultations: Available via telemedicine, including the option to Skype or FaceTime.
Watch MesoTV
This MesoTV interview was made possible by the support of sponsors who have stepped up during this difficult time to ensure that we can continue serving the mesothelioma community. Please take note of them at the beginning of the video: Novocure; Belluck & Fox, LLP; University of Pittsburgh Medical Center (UPMC); Vogelzang Law; and Merrill Lynch.
Get notified when our next video is published by clicking the red “Subscribe” button below.
MesoTV is the Mesothelioma Applied Research Foundation’s recorded video series covering pertinent conversations impacting the mesothelioma community. You can learn more at curemeso.org/mesotv.
